When limiting analyses to CHIP variants in CLL-related genes in combination with MBL, the effect on developing lymphoma dramatically increased by more than 6-fold (i.e., from 3.3-fold risk with MBL alone to 20.9-fold risk with the co-occurrence of MBL and CLL-related CHIP). The gene discussed is STUB1; the disease is lymphoma.